Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE SARRAZIN-FOUGERE : revenue, balance sheet and financial ratios

PHARMACIE SARRAZIN-FOUGERE is a French company founded 21 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in HIRSON (02500), this company of category PME shows in 2022 a revenue of 3.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE SARRAZIN-FOUGERE (SIREN 478329865)
Kennzahl 2024 2023 2022 2021 2020 2019 2018 2017
Umsatz N/C N/C 3 392 960 € N/C N/C N/C N/C N/C
Nettoergebnis 156 119 € 158 523 € 231 330 € 200 354 € 310 266 € 65 970 € 108 529 € 144 301 €
EBITDA N/C N/C 350 919 € N/C N/C N/C N/C N/C
Nettomarge N/C N/C 6.8% N/C N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2024, PHARMACIE SARRAZIN-FOUGERE generates positive net income of 156 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 144 k€ -> 156 k€.

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

156 119 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 41%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

40.844%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

64.128%

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

18.4%

Entwicklung der Solvenzkennzahlen
PHARMACIE SARRAZIN-FOUGERE

Positionnement sectoriel

Debt ratio
40.84 2024
2022
2023
2024
Q1: 16.46
Méd: 58.47
Q3: 154.89
Good

In 2024, the debt ratio of PHARMACIE SARRAZIN-FOUGERE (40.84) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
64.13% 2024
2022
2023
2024
Q1: 28.91%
Méd: 49.95%
Q3: 69.47%
Good +5 pts über 3 Jahre

In 2024, the financial autonomy of PHARMACIE SARRAZIN-FOUGERE (64.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
3.53 years 2022
2022
Q1: 1.29 years
Méd: 3.55 years
Q3: 6.63 years
Good

In 2022, the repayment capacity of PHARMACIE SARRAZIN-FOUGERE (3.53) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 429.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

429.514

Entwicklung der Liquiditätskennzahlen
PHARMACIE SARRAZIN-FOUGERE

Positionnement sectoriel

Liquidity ratio
429.51 2024
2022
2023
2024
Q1: 129.47
Méd: 182.13
Q3: 260.78
Excellent

In 2024, the liquidity ratio of PHARMACIE SARRAZIN-FOUGERE (429.51) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
2.78x 2022
2022
Q1: 0.74x
Méd: 2.5x
Q3: 5.15x
Good

In 2022, the interest coverage of PHARMACIE SARRAZIN-FOUGERE (2.8x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operatives Working Capital (2024) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

0 €

Kundenforderungen (2024) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

0 j

Lieferantenverbindlichkeiten (2024) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

0 j

Lagerumschlag (2024) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Entwicklung des Working Capital und der Zahlungsfristen
PHARMACIE SARRAZIN-FOUGERE

Positionnement de PHARMACIE SARRAZIN-FOUGERE dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE SARRAZIN-FOUGERE is estimated at 2 179 536 € (range 1 517 794€ - 3 260 711€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1517k€ 2179k€ 3260k€
2 179 536 € Range: 1 517 794€ - 3 260 711€
NAF 5 année 2024

Valuation method used

Net Income Multiple
156 119 € × 14.0x = 2 179 537 €
Range: 1 517 795€ - 3 260 712€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE SARRAZIN-FOUGERE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE SARRAZIN-FOUGERE

What is the revenue of PHARMACIE SARRAZIN-FOUGERE ?

The revenue of PHARMACIE SARRAZIN-FOUGERE in 2022 is 3.4 M€.

Is PHARMACIE SARRAZIN-FOUGERE profitable?

Yes, PHARMACIE SARRAZIN-FOUGERE generated a net profit of 156 k€ in 2024.

Where is the headquarters of PHARMACIE SARRAZIN-FOUGERE ?

The headquarters of PHARMACIE SARRAZIN-FOUGERE is located in HIRSON (02500), in the department Aisne.

Where to find the tax return of PHARMACIE SARRAZIN-FOUGERE ?

The tax return of PHARMACIE SARRAZIN-FOUGERE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE SARRAZIN-FOUGERE operate?

PHARMACIE SARRAZIN-FOUGERE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.